1. Home
  2. KIRK vs LYRA Comparison

KIRK vs LYRA Comparison

Compare KIRK & LYRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KIRK
  • LYRA
  • Stock Information
  • Founded
  • KIRK 1966
  • LYRA 2005
  • Country
  • KIRK United States
  • LYRA United States
  • Employees
  • KIRK N/A
  • LYRA N/A
  • Industry
  • KIRK Diversified Commercial Services
  • LYRA Medical/Dental Instruments
  • Sector
  • KIRK Miscellaneous
  • LYRA Health Care
  • Exchange
  • KIRK Nasdaq
  • LYRA Nasdaq
  • Market Cap
  • KIRK 28.2M
  • LYRA 18.2M
  • IPO Year
  • KIRK 2002
  • LYRA 2020
  • Fundamental
  • Price
  • KIRK $1.96
  • LYRA $0.23
  • Analyst Decision
  • KIRK Buy
  • LYRA Buy
  • Analyst Count
  • KIRK 2
  • LYRA 5
  • Target Price
  • KIRK $4.50
  • LYRA $4.50
  • AVG Volume (30 Days)
  • KIRK 102.1K
  • LYRA 631.9K
  • Earning Date
  • KIRK 11-29-2024
  • LYRA 11-05-2024
  • Dividend Yield
  • KIRK N/A
  • LYRA N/A
  • EPS Growth
  • KIRK N/A
  • LYRA N/A
  • EPS
  • KIRK N/A
  • LYRA N/A
  • Revenue
  • KIRK $460,353,000.00
  • LYRA $1,820,000.00
  • Revenue This Year
  • KIRK N/A
  • LYRA $13.99
  • Revenue Next Year
  • KIRK $0.84
  • LYRA N/A
  • P/E Ratio
  • KIRK N/A
  • LYRA N/A
  • Revenue Growth
  • KIRK N/A
  • LYRA 47.01
  • 52 Week Low
  • KIRK $1.39
  • LYRA $0.21
  • 52 Week High
  • KIRK $3.54
  • LYRA $6.79
  • Technical
  • Relative Strength Index (RSI)
  • KIRK 50.29
  • LYRA 41.93
  • Support Level
  • KIRK $1.93
  • LYRA $0.22
  • Resistance Level
  • KIRK $2.05
  • LYRA $0.24
  • Average True Range (ATR)
  • KIRK 0.10
  • LYRA 0.02
  • MACD
  • KIRK -0.03
  • LYRA 0.00
  • Stochastic Oscillator
  • KIRK 11.54
  • LYRA 37.59

About KIRK Kirkland's Inc. COMMONSTOCK

Kirkland's Inc is a specialty retailer of home decor and gifts in the United States. The company stores provide various merchandise, including holiday decor, value pricing, and a stimulating in-store and online environment that provides customers with a brand experience. The company stores also offer an assortment of holiday merchandise in seasonal periods, as well as items that are suitable for gift-giving.

About LYRA Lyra Therapeutics Inc.

Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. The Company's operations and manages its business as a single operating segment which is the business of developing targeted medicines to address ears, nose, and throat, or ENT diseases. Its initial product candidates, LYR-210 and LYR-220, are bioresorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver up to six months of continuous drug therapy to the sinonasal passages for the treatment of chronic rhinosinusitis, or CRS.

Share on Social Networks: